PT Diagnos Laboratorium Utama Tbk (IDX:DGNS)
Indonesia · Delayed Price · Currency is IDR 224.00
-2.00 (-0.88%)
Jul 15, 2026, 4:02 PM WIB
IDX:DGNS Market Cap
IDX:DGNS has a market cap or net worth of 282.5 billion as of July 15, 2026. Its market cap has increased by 43.04% in one year.
Market Cap
282.50B
Enterprise Value
353.02B
Revenue
171.06B
Ranking
n/a
PE Ratio
84.42
Stock Price
224.00
Market Cap Chart
Since January 15, 2021, IDX:DGNS's market cap has decreased from 337.50B to 282.50B, a decrease of -16.30%. That is a compound annual growth rate of -3.18%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 15, 2026 | 282.50B | 22.83% |
| Dec 30, 2025 | 230.00B | -5.64% |
| Dec 30, 2024 | 243.75B | -20.73% |
| Dec 29, 2023 | 307.50B | 0.82% |
| Dec 30, 2022 | 305.00B | -67.25% |
| Dec 30, 2021 | 931.25B | 175.93% |
| Jan 15, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| PT Sejahteraraya Anugrahjaya Tbk | 134.63T |
| PT Kalbe Farma Tbk. | 32.81T |
| PT Siloam International Hospitals Tbk | 28.05T |
| PT Mitra Keluarga Karyasehat Tbk | 23.71T |
| PT Maja Agung Latexindo Tbk | 411.73B |
| PT Indofarma Tbk | 390.51B |
| PT Royal Prima Tbk | 324.32B |
| PT Ikapharmindo Putramas Tbk | 303.24B |